Naples Global Advisors’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.48M Buy
30,920
+6,675
+28% +$287K 0.09% 197
2026
Q1
$919K Sell
24,245
-8,427
-26% -$399K 0.07% 244
2025
Q4
$1.66M Buy
32,672
+7,345
+29% +$376K 0.12% 180
2025
Q3
$1.41M Buy
25,327
+8,586
+51% +$503K 0.11% 194
2025
Q2
$1.16M Buy
16,741
+4,977
+42% +$339K 0.1% 211
2025
Q1
$829K Buy
+11,764
New +$972K 0.08% 239

Other funds holding NVO

Naples Global Advisors's NVO Position: Q2 2026 in Review

Naples Global Advisors increased its Novo Nordisk (NVO) stake by 28% in Q2 2026, buying an estimated $287K and bringing the position to 30,920 shares worth $1.48M. The position accounts for 0.09% of the portfolio, ranked #197.

Naples Global Advisors first reported a position in NVO in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.66M in Q4 2025. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Naples Global Advisors held 30,920 shares of Novo Nordisk worth $1.48M as of Q2 2026.
  • Naples Global Advisors bought 6,675 Novo Nordisk shares in Q2 2026, an estimated $287K.
  • Novo Nordisk made up 0.09% of Naples Global Advisors's portfolio in Q2 2026, its #197 holding.
  • Naples Global Advisors first reported a position in Novo Nordisk in Q1 2025 and has held it in 6 quarters since.
  • Naples Global Advisors's Novo Nordisk position peaked at $1.66M in Q4 2025.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Naples Global Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.